## GM: General Motors Company - XLY: Consumer Cyclical

### Executive Summary

No thesis match: MRS_20 -0.7% below STRENGTH zone (4.0-10.0%); PEG 1.85 fails VALUE criteria (<1.0). Stock is in no-man's land without clear edge. Caution: momentum weakening (-2.5% MRS).

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($78.88)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_20 falling below -5% or breaking key support

### News

- **Articles:** 10
- **Sentiment:** Neutral (Bullish: 4, Bearish: 2)

**1. General Motors' Q4 US Sales Fall 7% Y/Y: Is EV Weakness the Reason?**
- Source: TradingView â€” Track All Markets | 20260107T151220 | Neutral | Relevance: 100%
- General Motors reported a 7% year-over-year decline in Q4 2025 US sales, delivering 703,001 vehicles, with EV sales sharply dropping by 43%. Despite this quarterly dip, the company led the U.S. auto market for the full year, increasing sales by 6% and maintaining its leadership in full-size pickups and SUVs. This performance contrasts with rivals like Tesla and Ford, who showed mixed results in the same period.

**2. GM: Fourth-Quarter Sales Down, but Full Year Excellent**
- Source: Morningstar | 20260106T191413 | Somewhat-Bullish | Relevance: 100%
- General Motors' US sales in the fourth quarter fell 6.9% year over year, though full-year sales increased by 5.5%. Despite a drop in EV sales for the quarter, key vehicles like full-size pickups and certain SUVs performed well, contributing to strong overall yearly results. Morningstar maintains its "no-moat" rating and $80 fair value estimate for GM, noting the company's low discounting in 2025 suggests flexibility for 2026 amid an expected industry sales decline.

**3. GM Tops US Auto Sales in 2025 Despite Q4 Dip: Time to Buy the Stock?**
- Source: The Globe and Mail | 20260106T181017 | Bullish | Relevance: 100%
- General Motors (GM) led US auto sales in 2025, selling 2.85 million units, a 5.5% increase, despite a 7% dip in Q4 sales and a 43% drop in EV deliveries during the same period. The company's market share grew to 17%, and it maintained its leadership in full-size pickups for the sixth consecutive year. Despite the Q4 slowdown, GM's strong market position, growth in software services, and restructuring efforts in China, coupled with a robust liquidity profile and stock buybacks, suggest it remains an attractive investment.

**4. GM Tops US Auto Sales in 2025 Despite Q4 Dip: Time to Buy the Stock?**
- Source: The Globe and Mail | 20260106T180004 | Bullish | Relevance: 100%
- General Motors (GM) led U.S. auto sales in 2025, with a 5.5% increase in deliveries, outperforming Toyota. Despite a 7% dip in Q4 sales, including a 43% drop in EV deliveries, GM anticipates resilient demand into 2026 and sees strong growth in its software and services business. Analysts recommend GM as a "Strong Buy" due to its undervaluation compared to peers and positive profit growth outlook.

**5. General Motors laying off over 1,100 employees**
- Source: WKZO | 20260106T073800 | Bearish | Relevance: 100%
- General Motors is laying off over 1,100 workers from its Factory Zero in Hamtramck, Michigan. This reduction in workforce is permanent, affecting half of UAW Local 22's membership. The layoffs are attributed to a shift in electric vehicle demand.

### Analyst Activity

**Target Signal:** VERY_BULLISH (Raises: 5, Lowers: 0)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-18 | Wedbush | $95 | $75 | +27% |
| 2025-12-15 | UBS | $97 | $85 | +14% |
| 2025-12-09 | Wells Fargo | $48 | $46 | +4% |
| 2025-12-09 | Goldman Sachs | $93 | $81 | +15% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-18 | Wedbush | main | Outperform |
| 2025-12-15 | UBS | main | Buy |
| 2025-12-09 | Wells Fargo | main | Underweight |
| 2025-12-09 | Goldman Sachs | main | Buy |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_BUYING** |
| Buys | 11 ($0.78M) |
| Sells | 2 ($0.00M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 41.7% |
| Smart Money | **BEARISH** |
| Net Flow | 0.0% |
| Buying/Selling | 5 / 5 |

**Top Holders:**
- Vanguard Group Inc: 11.8% (-1.1%)
- Blackrock Inc.: 9.4% (+1.9%)
- State Street Corpora: 5.0% (-4.3%)
- Franklin Resources, : 3.4% (+3.3%)
- Greenhaven Associate: 2.5% (-2.5%)

### Key Risks

1. Momentum deterioration: MRS_20 falling (-2.5% 5d) with bearish MACD, trend may be turning.
2. Market regime shift could impact momentum names disproportionately.
3. Sector rotation risk if leadership changes from current market theme.

### Catalysts

- Analyst target momentum: 5 raises (avg +25%) could attract flows.
- Broader market risk-on sentiment could lift quality names.

### Fundamentals

PEG ratio 1.85 elevated, pricing in significant growth expectations. Forward P/E 7.0x attractive for 13% earnings growth. Balance sheet: $5.0B free cash flow. Analyst sentiment positive (5 raises, avg +25%). Insider buying signal ($0.8M), management confidence. Institutional flow bearish (5 selling vs 5 buying).

| Metric | Value |
|--------|-------|
| Market Cap | $78.0B |
| Beta | 1.32 |
| 52W Range | $41.60 - $83.68 |
| Short Interest | 2.5% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 1.85 |
| Forward P/E | 7.0 |
| Current P/E | 8.0 |
| YoY Growth | 13.3% |
| EPS Direction | RISING |

### Technicals

MRS_20 deteriorating from 1.8% to -0.7% (-2.5% in 5 days), indicating relative weakness vs NASDAQ. Below STRENGTH zone by 4.7pp (needs >4.0% for momentum thesis). Full SMA alignment bullish (above 20/50/200 SMAs). OFD pattern: -SBL (Volatile).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_20 | -0.68% (CS: 46) | Neutral |
| RSI_14 | 62.1 | Neutral |
| MACD Histogram | -0.50 | Bearish |
| vs SMA20 | 1.003x | Above |
| vs SMA50 | 1.089x | Above |
| vs SMA200 | 1.407x | Above |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $81.92
- **Stop Loss:** $78.88 (3.7% risk)
- **Target:** $84.96 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 164
- **Position Value:** $13,434.88
- **Portfolio %:** 13.43%
- **Risk Dollars:** $500.00
- **Risk Per Trade:** 0.50%
- **Modifiers:** L1 100% | L2 50% | Combined 0.50x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.00x |
| L2 Sector | AVOID (Zone C) | 0.50x |

*NORMAL regime with balanced risk appetite. VIX at 15.38 sits in the normal range (18th percentile of 52-week) with modest upward drift, while yield curve remains positively sloped (+62bps 10Y-3M) supporting risk assets. Breadth at 59.5% shows healthy participation, though elevated put/call ratio (1.12) suggests some hedging activity. FOMC 20 days out provides runway for current conditions to persist.*

### Earnings

**Next:** 2026-01-27 (Est: $2.19)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $2.32 | $2.80 | +20.5% |
| 2025Q2 | $2.48 | $2.53 | +2.1% |
| 2025Q1 | $2.67 | $2.78 | +4.3% |
| 2024Q4 | $1.84 | $1.92 | +4.3% |

---
*RULE-based L3 | 2026-01-08 08:02 | MRS_20*